As of November 28, 2024, 50 million shares of our common stock were available for future awards under our equity compensation plans, including 11 million shares approved for issuance under our employee stock purchase plan (“ESPP”).

Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”)


Three months ended	November 28, 2024		November 30, 2023

Restricted stock award shares granted	10		12
Weighted-average grant-date fair value per share	$	100.95	$	67.36

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $101 million and $99 million was capitalized and remained in inventory as of November 28, 2024 and August 29, 2024, respectively.


Three months ended	November 28, 2024		November 30, 2023

Stock-based compensation expense by caption
Cost of goods sold	$	90	$	67
Research and development	77		68
Selling, general, and administrative	50		47
	$	217	$	182

Stock-based compensation expense by type of award
Restricted stock awards	$	192	$	163
ESPP	25		19
	$	217	$	182

As of November 28, 2024, $2.14 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the first quarter of 2029, resulting in a weighted-average period of 1.4 years.